Therapeutic Vaccines Market Size, Share, Growth Analysis, By Product Type(Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines), By Type(Protein-based Vaccines, DNA Vaccines, Recombinant Vector Vaccines, Conjugate Vaccines), By Application(Cancer, HIV/AIDS Vaccines, Infectious Diseases Vaccines, Allergy Vaccines), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35J2111 | Region: Global | Published Date: May, 2024
Pages: 215 | Tables: 95 | Figures: 78

Therapeutic Vaccines Market Insights

Global Therapeutic Vaccines Market size was valued at USD 25.7 billion in 2022 and is poised to grow from USD 53.71 billion in 2023 to USD 119.39 billion by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

Therapeutic vaccines are given to the patient undergoing treatment from disease to strengthen immune response and promote better recovery. Growing use of therapeutic vaccine to improve the chances of successful treatment of patients affected with chronic diseases is driving market growth, High incidence of chronic diseases and rising investments in R&D of novel vaccines are also forecasted to benefit sales of therapeutic vaccine in the future. Rising awareness regarding preventive healthcare and growing demand for personalized medicine around the world are also estimated to boost the demand for therapeutic vaccine over the coming years. On the contrary, complexity in research and development process and limited efficacy are projected to be key restraints for therapeutic vaccine market development in the long run. Therapeutic vaccine companies can open up new avenues of opportunities by integrating their products with different immunotherapies and precision medicine going forward.

Therapeutic Vaccines Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Therapeutic Vaccines Market size was valued at USD 25.7 billion in 2022 and is poised to grow from USD 53.71 billion in 2023 to USD 119.39 billion by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

Therapeutic vaccine manufacturers should invest heavily in R&D of new vaccines that are more effective than what’s currently available in the market. Therapeutic vaccine companies can also collaborate and partner with each other to fast track the development of new vaccines and reduce time-to-market. Mergers and acquisitions are also popular strategies that could help therapeutic vaccine market players maximize their market share and presence. 'Novartis', 'Argos Therapeutics', 'Johnson & Johnson', 'Pfizer', 'Vaccinogen Inc.', 'Affiris', 'Antigenics', 'Bavarian Nordic', 'Biovest International', 'AstraZeneca', 'Merck & Co.', 'Dynavax Technologies Corporation', 'GlaxoSmithKline', 'Sanofi', 'Intellect Neurosciences', 'Agenus Inc.', 'Celldex Therapeutics', 'Cel-Sci', 'Curevac', 'Celtic Pharma', 'CSL Limited', 'Medimmune'

Surge in incidence of infectious and chronic diseases around the world has increased awareness regarding preventive healthcare among people around the world, which in turn, is forecasted to benefit sales of therapeutic vaccines.

Use in Immunotherapy: Therapeutic vaccine vendors can focus on developing new products that can be used in specific immunotherapies to improve the treatment and efficacy rate among cancer patients. Therapeutic vaccine companies can modify immune responses as per tumor and improve the chances of successful immunotherapy.

North America is estimated to account for a substantial share of the therapeutic vaccines market owing to the presence of a developed healthcare ecosystem and high healthcare expenditure. Growing investments in R&D of novel therapeutic vaccines in this region will also aid the dominance of this region in the market. The United States is projected to spearhead the demand for therapeutic vaccine in North America followed by Canada across the forecast period and beyond. An established clinical trial and regulatory approval system in the United States helps therapeutic vaccine market growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Therapeutic Vaccines Market Insights

Therapeutic Vaccines Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Therapeutic Vaccines Market?

Who are the key vendors in the Therapeutic Vaccines Market?

What is the key driver of Therapeutic Vaccines Market?

What is the key market trend for Therapeutic Vaccines Market?

Which region accounted for the largest share in Therapeutic Vaccines Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300